The world’s largest pharmaceutical company, Pfizer, is suing the Philippine government for having imported and registered - but not marketed - a product that is still under patent. At the same time, industry is said to be lobbying against a bill under consideration in the Philippines that would introduce more flexibilities into the country’s intellectual property law, according to sources.